Literature DB >> 3094288

The biochemical basis for the distinction between the two Cryptococcus neoformans varieties with CGB medium.

K H Min, K J Kwon-Chung.   

Abstract

The biochemical basis for the reaction to canavanine-glycine-bromthymol blue (CGB) agar by Cryptococcus neoformans var. gattii and C. neoformans var. neoformans was investigated. All of the var. gattii isolates tested were found to utilize glycine as the sole source of carbon and nitrogen and were resistant to L-canavanine. Only 11% of the serotype D isolates of var. neoformans utilized glycine as the sole source of carbon and nitrogen, but these were all sensitive to canavanine. Nineteen percent of the serotype A isolates of var. neoformans were able to assimilate glycine, and 81% of the glycine users were resistant to canavanine. However, these canavanine-resistant, glycine-assimilating, var. neoformans isolates failed to grow when they were cultured on a medium containing glycine and canavanine. Unlike the var. neoformans isolates, all of the var. gattii isolates tested grew on a medium that contained both of these compounds. Glycine-utilizing isolates exhibited good uptake of the amino acid, and a glycine-cleaving enzyme was discernable in the isolate. The isolates that fail to utilize glycine accumulated the amino acid at a rate which was barely 15% of that seen in the glycine users, and no glycine-cleaving enzyme was apparent within the 48-hr incubation period. When a cell-free extract (which had been derived from a glycine-utilizing isolate), was incubated with 14C-labeled glycine, ammonia, radiolabeled CO2, and serine were produced. The glycine decarboxylase activity of the cell-free extract was found to be enhanced by the addition of dithiothreitol, tetrahydrofolate, pyridoxal phosphate, and nicotinamide adenine dinucleotide (NAD). The ammonia released during glycine cleavage seems to be responsible for the positive reaction on CGB medium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094288     DOI: 10.1016/s0176-6724(86)80079-7

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  9 in total

Review 1.  Microreview: capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Atsuhiko Hasegawa; Toshi Watanabe
Journal:  Mycopathologia       Date:  2007-01       Impact factor: 2.574

2.  Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Lisa R McTaggart; Eric Lei; Susan E Richardson; Linda Hoang; Annette Fothergill; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

3.  Cryptococcosis in patients living with hepatitis C and B viruses.

Authors:  Fernanda Sá Spies; Markus Berger de Oliveira; Monique Siebra Krug; Cecilia Bittencourt Severo; Luiz Carlos Severo; Marilene Henning Vainstein
Journal:  Mycopathologia       Date:  2014-12-21       Impact factor: 2.574

4.  Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing.

Authors:  Lisa McTaggart; Susan E Richardson; Christine Seah; Linda Hoang; Annette Fothergill; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

5.  Karyotyping of Cryptococcus neoformans as an epidemiological tool.

Authors:  J R Perfect; N Ketabchi; G M Cox; C W Ingram; C L Beiser
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

6.  Investigation of the basis of virulence in serotype A strains of Cryptococcus neoformans from apparently immunocompetent individuals.

Authors:  Cletus A D'Souza; Ferry Hagen; Teun Boekhout; Gary M Cox; Joseph Heitman
Journal:  Curr Genet       Date:  2004-05-19       Impact factor: 3.886

7.  Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing.

Authors:  K R Klein; L Hall; S M Deml; J M Rysavy; S L Wohlfiel; N L Wengenack
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

8.  Cryptococcus deuterogattii VGIIa Infection Associated with Travel to the Pacific Northwest Outbreak Region in an Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibody-Positive Patient in the United States.

Authors:  Shelly Applen Clancey; Emily J Ciccone; Marco A Coelho; Joie Davis; Li Ding; Renee Betancourt; Samuel Glaubiger; Yueh Lee; Steven M Holland; Peter Gilligan; Julia Sung; Joseph Heitman
Journal:  mBio       Date:  2019-02-12       Impact factor: 7.867

Review 9.  The interplay of phenotype and genotype in Cryptococcus neoformans disease.

Authors:  Sophie Altamirano; Katrina M Jackson; Kirsten Nielsen
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.